Eucrisa OverviewCrisaborole (trade name Eucrisa) is a nonsteroidal topical medication used for the treatment of mild-to-moderate atopic dermatitis (eczema) in people two years or older. It was approved by U.S. Food and Drug Administration on Dec 14, 2016. Contents 1 Mechanism of action 2 Chemistry 3 History 4 See also 5 References Mechanism of action It is a phosphodiesterase-4 inhibitor, mainly acting on phosphodiesterase 4B (PDE4B), which c...
Read more Eucrisa Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Crisaborole
Recent Eucrisa Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Ointment: 2%
NDC Database Records for Eucrisa: (1 result)Sorted by National Drug Code
- 55724-211 Eucrisa 20 mg/g Topical Ointment by Anacor Pharmaceuticals, Inc.